Rachael Hernandez, PHARMD
Pharmacist Clinician (Phc)/ Clinical Pharmacy Specialist · Santa Clara
- Medicare standing
- 1 flag on the record
- Listed below.
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
On the public record
- Medicare does not list them as allowed to order and refer
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Rachael Hernandez’s office at (408) 851-3929 to ask if they take your plan before you enroll.
California Medical Board record
Licence A77498 · Current
Licensed to practise in California · since 2001 · expires 2027-03-31 · University of California, Irvine College of Medicine.
Matched on the licence number without its letter prefix; check the name before relying on it.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Anesthesiology - Anesthesiology
Drugs they prescribed that Part D paid
$41,503
Pharmacies billed $41,503 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 148) in 2024. At or below the middle of the specialty; the typical pharmacist clinician is at 0%.
99 generic and 49 brand-name prescriptions · $41,503 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Nivestym | 38 | $34,065 | $896 |
| Granix | 11 | $6,117 | $556 |
| Prochlorperazine Maleate | 35 | $516 | $15 |
| Dexamethasone | 22 | $376 | $17 |
| Ondansetron | 29 | $233 | $8 |
Year by year
| 2024 | 148 | 68 | 0% (0) | 33% | $41,503 |
| 2023 | 125 | 56 | 0% (0) | 33% | $34,503 |
| 2022 | 139 | 57 | 0% (0) | 12% | $14,098 |
| 2021 | 183 | 86 | 0% (0) | 10% | $18,550 |
| 2020 | 140 | 65 | 0% (0) | 8% | $31,281 |
| 2019 | 61 | 31 | 0% (0) | None | $2,071 |
| 2018 | 15 | None | 0% (0) | 0% | $290 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 4 drugs
| Nivestym | 41 | $33,301 | $812 |
| Prochlorperazine Maleate | 39 | $505 | $13 |
| Dexamethasone | 17 | $451 | $27 |
| Ondansetron | 24 | $209 | $9 |
2022: 4 drugs
| Nivestym | 11 | $7,656 | $696 |
| Prochlorperazine Maleate | 43 | $822 | $19 |
| Dexamethasone | 16 | $612 | $38 |
| Ondansetron | 49 | $456 | $9 |
2021: 4 drugs
| Zarxio | 19 | $14,910 | $785 |
| Prochlorperazine Maleate | 51 | $1,072 | $21 |
| Dexamethasone | 27 | $1,002 | $37 |
| Ondansetron | 69 | $745 | $11 |
2020: 4 drugs
| Zarxio | 11 | $27,958 | $2,542 |
| Dexamethasone | 29 | $1,334 | $46 |
| Prochlorperazine Maleate | 46 | $967 | $21 |
| Ondansetron | 38 | $341 | $9 |
2019: 3 drugs
| Dexamethasone | 15 | $679 | $45 |
| Prochlorperazine Maleate | 22 | $370 | $17 |
| Ondansetron | 17 | $152 | $9 |
Professional record
- NPI
- 1700390705
- Licence
- CA 77498California A77498: Current · expires 2027-03-31
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 1835P0018X (1835P0018X)
- Mailing address
- 710 Lawrence Expy Dept 362, Santa Clara, CA, 95051
- NPI first listed
- 2017-11-29
- NPI last updated
- 2022-03-07
- NPI record certified
- 2022-03-07
This is when the NPI record was last certified, not a medical board exam.
This office lists an electronic records connection.